22
Reviewed transactions
19
With price data
4.5x
Median EV or valuation / revenue
17.8x
Median EV or valuation / EBITDA
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2023 | 6 | 6 | 4.2x | 22.0x |
| 2022 | 3 | 2 | 4.9x | 21.4x |
| 2021 | 6 | 5 | 4.7x | 15.2x |
Sortable transaction comps
Beauty transaction table
Rows with reported value
19 / 22
Acquisition value, USD
USD 12B
Investment capital, USD
USD 84.0M
Median EV or valuation / revenue
4.5x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
22 shown of 22 matching transactions. Click any transaction row for more detail.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Beautynova Control | 2024-03-18 | PAI Partners | EUR 330M | 365 | 2.5x | 10.6x | Italy | Estimated 1 source | ||
| Dr. Barbara Sturm Control | 2024-01-01 | Puig | EUR 320M | 354 | 5.0x | - | - | Estimated 2 sources | ||
| Go-To Skincare Control | 2023-12-15 | Zoë Foster Blake | AUD 21.8M Consideration | 15 | - | - | Australia | Confirmed 1 source | ||
| Straand Capital Raise | 2023-12-10 | Unilever Ventures | USD 4.0M Investment Amount | 4 | - | - | Australia | Confirmed 1 source | ||
| COSRX Control (38%) | 2023-10-30 | Amorepacific | USD 1.0B | 1,000 | 3.6x | - | South Korea | Confirmed 2 sources | ||
| Naturium Control | 2023-08-29 | Elf | EUR 328M | 354 | 3.9x | 20.9x | US (California) | Estimated 1 source | ||
| Aesop Control | 2023-04-03 | L’Oréal | EUR 2.2B Consideration | 2,500 | 4.4x | 24.7x | Australia | Confirmed 2 sources | ||
| Mielle Organics Control | 2023-01-11 | P&G Beauty | EUR 595M | 639 | 5.6x | 22.0x | - | Confirmed 2 sources | ||
| Nutrafol Control | 2022-05-30 | Unilever | Undisclosed Undisclosed | Undisclosed | 4.9x | 22.7x | - | Confirmed 1 source | ||
| NAK Hair Control | 2022-05-01 | Adamantem Capital | AUD 90.0M | 65 | 2.3x | - | Australia | Estimated 1 source | ||
| Ilia Beauty Control | 2022-02-01 | Courtin-Clarins family / Clarins | EUR 612M | 689 | 7.0x | 20.0x | - | Estimated 2 sources | ||
| Chantecaille Control | 2021-12-21 | Beiersdorf | EUR 609M | 688 | 4.6x | 15.3x | - | Confirmed 1 source | ||
| E45 Control | 2021-12-01 | Karo Healthcare | Undisclosed | Undisclosed | 4.7x | - | - | Confirmed 1 source | ||
| Obagi Control | 2021-11-15 | Waldencast | EUR 756M | 865 | 4.5x | 17.2x | - | Confirmed 1 source | ||
| Milk Makeup Control | 2021-11-15 | Waldencast Acquisition Corp. | EUR 337M | 386 | 5.8x | - | US (NY) | Estimated 1 source | ||
| Vegamour Minority | 2021-04-13 | General Atlantic | USD 80.0M Investment Amount | 80 | 3.0x | 15.0x | - | Confirmed 1 source | ||
| Go-To Skincare Control (50%) | 2021-03-01 | BWX | AUD 178M | 138 | 4.8x | 14.9x | Australia | Estimated 2 sources | ||
| Cremo Control | 2020-08-04 | Edgewell Personal Care | USD 235M Consideration | 235 | 4.1x | - | US | Confirmed 1 source | ||
| Thayers Natural Remedies Control | 2020-06-18 | L'Oréal | USD 400M Rumored Value | 400 | 7.3x | 13.3x | - | Estimated 1 source | ||
| Filorga Control | 2019-07-11 | Colgate-Palmolive | EUR 1.5B Equity Purchase Price | 1,690 | 8.3x | - | France | Confirmed 4 sources | ||
| Ci:z Holdings Co., Ltd. Control | 2018-10-23 | Johnson & Johnson | USD 2.1B | 2,100 | 4.5x | 22.0x | Japan | Confirmed 1 source | ||
| Viviscal Control | 2017-01-20 | Church & Dwight | Undisclosed | Undisclosed | 3.6x | 17.8x | - | Confirmed 1 source |
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.